Skip to main content
    I

    Innate Pharma (IPHA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.33
    -0.08 (-5.34%)

    Market Cap: $156.94M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Innate Pharma (IPHA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Innate Pharma (IPHA) has a latest price of $1.33 on Nov 17, 2026, 50.9% below its 52-week high of $2.71. Its price fell 26.9% over the past 12 months. The month-end price fell 74.8% over the 5 years through Oct 2026, a compound annual decline of 24.1%.

    Price Chart

    From Oct 2019 to Oct 2026, its highest month-end close was $7.60 in Apr 2020 and its lowest $1.28 in Mar 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart IPHA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IPHA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 37.3%, and over 6 months it fell 34.5%. The month-end price fell 40.9% over the 3 years through Oct 2026, a compound annual decline of 16.1%.

    PeriodChange
    1 month-8.9%
    3 months-37.3%
    6 months-34.5%
    12 months-26.9%
    12 months, with dividends-26.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-40.9%-16.1%
    5 years-74.8%-24.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 11.5%, and its weakest was 2020, when it fell 36.5%.

    YearCloseChange
    2026 through Oct 2026$1.46-16.6%
    2025$1.75-4.9%
    2024$1.84-34.3%
    2023$2.80-24.9%
    2022$3.73-18.2%
    2021$4.56+11.5%
    2020$4.09-36.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 16.3% below its 50-day average of $1.59 and 21.4% below its 200-day average of $1.69.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.33
    52-week high$2.71-50.9%
    52-week low$1.17+13.7%
    50-day average$1.59-16.3%
    200-day average$1.69-21.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 61.3%.

    MeasureValue
    1-year beta1.30
    Largest fall, 1 year-47.5%
    Largest fall, 3 years-61.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About IPHA

    What is IPHA's 1-year price change?

    Innate Pharma's price fell 26.9% over the past 12 months. With dividends included, the 12-month total return was -26.9%.

    What is IPHA's 5-year price change?

    Innate Pharma's month-end price fell 74.8% over the 5 years through Oct 2026, a compound annual decline of 24.1%. These figures leave out dividends.

    What is IPHA's 52-week high and low?

    Innate Pharma's 52-week high is $2.71 and its 52-week low is $1.17. Its latest price of $1.33 on Nov 17, 2026 is 50.9% below the high.

    What is IPHA's beta?

    Innate Pharma's 1-year beta against the S&P 500 is 1.30, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 47.5%.

    Is the IPHA chart free?

    Yes. Advanced Charting for IPHA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.